JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrell, M. D.
Right arrow Articles by Stimers, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrell, M. D.
Right arrow Articles by Stimers, J. R.

Vol. 303, Issue 1, 347-355, October 2002

Differential Effects of Linoleic Acid Metabolites on Cardiac Sodium Current

Maddison D. Harrell and Joseph R. Stimers

Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (J.R.S.); and Tulane University, New Orleans, Louisiana (M.D.H.)

9,10-Epoxy-12-octadecenoic acid (EOA), a metabolite of linoleic acid, causes cardiac arrest in dogs. Other metabolites of linoleic acid also have toxic effects. This study investigates the mechanism of action of four of these compounds on cardiac Na+ current (INa). The whole-cell patch-clamp technique was used to investigate the effects of EOA, 9,10-dihydroxy-12-octadecenoic acid (DHOA), and their corresponding methyl esters (9,10-epoxy-12-octadecenoic methyl ester, EOM; and 9,10-dihydroxy-12-octadecenoic methyl ester, DHOM) on INa in isolated adult rat ventricular myocytes. Extracellular application of each compound elicited a concentration-dependent inhibition of INa. The dose-response curve yielded 50% inhibition concentrations of 301 ± 117 µM for DHOA, 41 ± 6 µM for DHOM, 34 ± 5 µM for EOA, and 160 ± 41 µM for EOM. Although there was no effect on activation, 50 µM DHOM, EOA, and EOM significantly hyperpolarized the steady-state inactivation curve by approximately -6 mV. Furthermore, EOM significantly increased the slope of the steady-state inactivation curve. These compounds also seemed to stabilize the inactivated state because the time for recovery from inactivation was significantly slowed from a control value of 12.9 ± 0.5 ms to 30.5 ± 3.3, 31.4 ± 1.4, and 20.5 ± 1.0 ms by 50 µM DHOM, EOA, and EOM, respectively. These compounds have multiple actions on Na+ channels and that despite their structural similarities their actions differ from each other. The steady-state block of INa suggests that either the pore is being blocked or the channels are prevented from gating to the open state. In addition, these compounds stabilize the inactivated state and promote increased population of a slower inactivated state.


0022-3565/02/3031-0347$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. W. Rhee, J. R. Stimers, W. Wang, and L. Pang
Vascular Smooth Muscle-Specific Knockdown of the Noncardiac Form of the L-Type Calcium Channel by MicroRNA-Based Short Hairpin RNA as a Potential Antihypertensive Therapy
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 775 - 782.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. W. Dreisbach, J. C. Rice, S. Japa, J. W. Newman, A. Sigel, R. S. Gill, A. E. Hess, A. C. Cemo, J. P. Fonseca, B. D. Hammock, et al.
Salt Loading Increases Urinary Excretion of Linoleic Acid Diols and Triols in Healthy Human Subjects
Hypertension, March 1, 2008; 51(3): 755 - 761.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.